Home » All » Stock Forecast » Monte Rosa Therapeutics Inc. Common Stock Forecast

Monte Rosa Therapeutics Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▲ +5.45%Market Cap $1.67B · Technical analysis Bullish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$21.24 ▲ +1.68%	Yesterday	$20.74 ▼ -0.71%	Tomorrow's Monte Rosa Therapeutics Inc. Common Stock (GLUE) setup is anchored to $20.89 and targets $21.24 (+1.68%). The near-term read is upside; watch $21.52 / $20.26 because daily realized volatility is about 8.00%.
Tomorrow's Monte Rosa Therapeutics Inc. Common Stock (GLUE) setup is anchored to $20.89 and targets $21.24 (+1.68%). The near-term read is upside; watch $21.52 / $20.26 because daily realized volatility is about 8.00%.
Week	$21.98 ▲ +5.23%	Last Week	$20.43 ▼ -2.19%	The 7-day Monte Rosa Therapeutics Inc. Common Stock model moves from $20.43 to $21.98 (+5.23%). It gives upside momentum context for this stock, so breaks around $21.52 / $20.26 matter more than a single tick.
The 7-day Monte Rosa Therapeutics Inc. Common Stock model moves from $20.43 to $21.98 (+5.23%). It gives upside momentum context for this stock, so breaks around $21.52 / $20.26 matter more than a single tick.
Month	$23.21 ▲ +11.13%	Last Month	$19.91 ▼ -4.67%	The 1-month Monte Rosa Therapeutics Inc. Common Stock target is $23.21 (+11.13%), compared with the live reference near $20.89. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Monte Rosa Therapeutics Inc. Common Stock target is $23.21 (+11.13%), compared with the live reference near $20.89. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$25.06 ▲ +19.98%	Last Year	$19.14 ▼ -8.39%	The 1-year Monte Rosa Therapeutics Inc. Common Stock scenario points to $25.06 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Monte Rosa Therapeutics Inc. Common Stock scenario points to $25.06 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$29.40 ▲ +40.71%	5 Years Ago	$17.32 ▼ -17.10%	The 5-year Monte Rosa Therapeutics Inc. Common Stock view is $29.40 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Monte Rosa Therapeutics Inc. Common Stock view is $29.40 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$21.24▲ +1.68%

Yesterday$20.74▼ -0.71%

Tomorrow's Monte Rosa Therapeutics Inc. Common Stock (GLUE) setup is anchored to $20.89 and targets $21.24 (+1.68%). The near-term read is upside; watch $21.52 / $20.26 because daily realized volatility is about 8.00%.

Week$21.98▲ +5.23%

Last Week$20.43▼ -2.19%

The 7-day Monte Rosa Therapeutics Inc. Common Stock model moves from $20.43 to $21.98 (+5.23%). It gives upside momentum context for this stock, so breaks around $21.52 / $20.26 matter more than a single tick.

Month$23.21▲ +11.13%

Last Month$19.91▼ -4.67%

The 1-month Monte Rosa Therapeutics Inc. Common Stock target is $23.21 (+11.13%), compared with the live reference near $20.89. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$25.06▲ +19.98%

Last Year$19.14▼ -8.39%

The 1-year Monte Rosa Therapeutics Inc. Common Stock scenario points to $25.06 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$29.40▲ +40.71%

5 Years Ago$17.32▼ -17.10%

The 5-year Monte Rosa Therapeutics Inc. Common Stock view is $29.40 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$20.89	Mid
Daily Change	+5.45%	Above
Volatility Cap	20.0%	Mid
Confidence	69%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$20.89

Daily Change+5.45%

Market Cap$1.67B

Sourcenasdaq-screener

Current	$20.89	Daily Change	+5.45%
Market Cap	$1.67B	Source	nasdaq-screener

Support & Resistance Levels

$20.26Support 1

$20.89Current

$21.52Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$20.89Live reference price

Used as the anchor for generated forecast calculations.

Next Month$23.21Model projection+11.13%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

69%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

69%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in GLUE today

Bullish Scenario

$21.93

+5.00% from current

Target Price$21.93

ScenarioUpside momentum

Probability61%

Base Scenario

$23.21

+11.13%

Target Price$23.21

ScenarioCapped drift

Probability69%

Bearish Scenario

$19.85

-5.00% from current

Target Price$19.85

ScenarioVolatility drawdown

Probability31%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 74/100

24H drift+1.68%

7D drift+5.23%

30D drift+11.13%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 70/100

1M outlook+11.13%

1Y outlook+19.98%

5Y outlook+40.71%

Frequently Asked Questions

Q What is the Monte Rosa Therapeutics Inc. Common Stock (GLUE) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Monte Rosa Therapeutics Inc. Common Stock is projected near $21.24 versus the current reference around $20.89. That implies a modeled move of +1.68% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for GLUE?

The weekly Monte Rosa Therapeutics Inc. Common Stock model points to $21.98, which maps to an expected drift of +5.23% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Monte Rosa Therapeutics Inc. Common Stock 1-month and 1-year targets?

The Monte Rosa Therapeutics Inc. Common Stock 1-month target is $23.21 (+11.13%), while the 1-year target is $25.06 (+19.98%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Monte Rosa Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The Monte Rosa Therapeutics Inc. Common Stock long-horizon scenario sits near $29.40 with a modeled change of +40.71%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are GLUE support and resistance zones right now?

For Monte Rosa Therapeutics Inc. Common Stock, nearest resistance is around $20.26, while nearest support is around $21.52. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Monte Rosa Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.